CN103006955A - Traditional Chinese medicine composition for treating asthma - Google Patents
Traditional Chinese medicine composition for treating asthma Download PDFInfo
- Publication number
- CN103006955A CN103006955A CN2013100247423A CN201310024742A CN103006955A CN 103006955 A CN103006955 A CN 103006955A CN 2013100247423 A CN2013100247423 A CN 2013100247423A CN 201310024742 A CN201310024742 A CN 201310024742A CN 103006955 A CN103006955 A CN 103006955A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- asthma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 208000006673 asthma Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 6
- 241001522129 Pinellia Species 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- 241000218176 Corydalis Species 0.000 claims description 7
- 241000237636 Pheretima Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 241000220262 Sinapis alba Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 238000002360 preparation method Methods 0.000 abstract description 7
- 244000140786 Brassica hirta Species 0.000 abstract description 5
- 238000012795 verification Methods 0.000 abstract description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000015763 Artemisia ludoviciana Nutrition 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000620709 Corydalis ambigua Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000608847 Gnaphalium Species 0.000 abstract 1
- 241000801118 Lepidium Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 241001233061 earthworms Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 13
- 208000000059 Dyspnea Diseases 0.000 description 8
- 206010013975 Dyspnoeas Diseases 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 208000037656 Respiratory Sounds Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010047924 Wheezing Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 206010011703 Cyanosis Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 206010037833 rales Diseases 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940124748 beta 2 agonist Drugs 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000012144 orthopnea Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating asthma. The traditional Chinese medicine composition for treating asthma is prepared from following raw medicinal materials in parts by weight: 25-35 parts of schisandra chinensis, 10-20 parts of herba geranii, 10-20 parts of affine cudweed, 8-16 parts of earthworms, 8-16 parts of bryozoatum, 8-16 parts of pepperweed seed, 15-25 parts of pinellia ternate, 15-25 parts of corydalis ambigua, 15-25 parts of salvia miltiorrhiza, 15-25 parts of white mustard seeds, 15-25 parts of poria cocos, 10-20 parts of flowering peach, 10-20 parts of wolfberry fruit, 7-13 parts of ephedra, 10-20 parts of almond, 7-13 parts of cassia twig, 15-25 parts of white paeony root and 8-16 parts of liquorice. The traditional Chinese medicine composition for treating asthma, disclosed by the invention, is prepared from pure traditional Chinese medicines, and has the advantages of simple and convenient preparation, low cost, remarkable curative effects, low side effects and the like; and the clinical verification shows that the effective rate of the traditional Chinese medicine composition for treating the asthma is 93%.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicine pharmacy, particularly relate to a kind of Chinese medicine composition for the treatment of asthma.
Background technology
Asthma is because trachea and bronchus can not adapt to the stimulation of various stimulus object, thereby and the bronchial muscular spasm that causes, mucosa swelling, secretions increase and cause bronchial stenosis; Its clinical symptom has cough, pants, dyspnea, uncomfortable in chest, expectoration etc.; Typical performance is ictal expiratory dyspnea with wheezing sound; Severe patient can be forced to take seat or be orthopnea, dry cough or cough up a large amount of white foam expectorant, even cyanosis etc. appears; Be universally acknowledged difficult medical problem, classified as one of four large pertinacious diseases in the disease by World Health Organization (WHO).
At present, the general employing continues atomizing and sucks β 2 agonist or anticholinergic agent clinically, vein glucocorticoid, or intravenous drip albuterol, aminophylline, or the medicine such as oral controlled-release theophylline; There is the deficiency that side effect is large, cure the symptoms, not the disease in said medicine; Therefore study and a kind ofly prepare that easy, cost is lowly treated, Chinese medicine composition evident in efficacy, treatment asthma that side effect is little is very necessary.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of asthma, the present invention has that preparation is easy, cost is lowly treated, evident in efficacy, the advantage such as side effect is little.
A kind of Chinese medicine composition for the treatment of asthma is characterized in that: the crude drug by following weight portion is made: Fructus Schisandrae Chinensis 25-35 part, Herba Erodii 10-20 part, Herba Gnaphalii Affinis 10-20 part, Pheretima 8-16 part, Pumex 8-16 part, Semen Lepidii (Semen Descurainiae) 8-16 part, Rhizoma Pinelliae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Salviae Miltiorrhizae 15-25 part, Semen Sinapis Albae 15-25 part, Poria 15-25 part, Fructus Pruni persicae immaturus 10-20 part, Fructus Lycii 10-20 part, Herba Ephedrae 7-13 part, Semen Armeniacae Amarum 10-20 part, Ramulus Cinnamomi 7-13 part, Radix Paeoniae Alba 15-25 part, Radix Glycyrrhizae 8-16 part.
The Chinese medicine composition of described treatment asthma, its preferably: the crude drug by following weight portion is made: 30 parts of Fructus Schisandrae Chinensis, 15 parts of Herba Erodiis, 15 parts of Herba Gnaphalii Affinis, 12 parts of Pheretimas, 12 parts of Pumexs, 12 parts of Semen Lepidii (Semen Descurainiae)s, 20 parts of the Rhizoma Pinelliaes, 20 parts of Rhizoma Corydalis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Semen Sinapis Albaes, 20 parts in Poria, 15 parts of Fructus Pruni persicae immaturuss, 15 parts of Fructus Lycii, 10 parts in Herba Ephedrae, 15 parts in Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 20 parts of the Radix Paeoniae Albas, 12 parts in Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment asthma may further comprise the steps:
(1) takes by weighing each crude drug according to described parts by weight;
Each crude drug that (2) will take by weighing is pulverized, is mixed;
(3) will get final product with the pack of every bag of 200-300 gram after the crude drug sterilization of mix homogeneously.
Usage and consumption: the Chinese medicine decocting of making is boiled into decoction, and every pair of medicine can decoct three times, patient's every day early, middle and late respectively taking once, 7 days is a course for the treatment of.
The beneficial effect that the present invention compared with prior art has is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, choose each crude drug and proportioning thereof, reach that conditioning lung qi, expectorant and asthma-curing, spleen invigorating consolidate, the effect of improving inspiration by invigorating the kidney, realize the purpose for the treatment of both the principal and the secondary aspects of a disease at the same time; The present invention is formed by pure traditional Chinese medicine, has that easy, the cost of preparation is lowly treated, evident in efficacy, the advantage such as side effect is little; Through clinical verification, it is 93% that the present invention treats the asthma effective percentage.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine composition for the treatment of asthma is made by the crude drug of following weight portion: 30 parts of Fructus Schisandrae Chinensis, 15 parts of Herba Erodiis, 15 parts of Herba Gnaphalii Affinis, 12 parts of Pheretimas, 12 parts of Pumexs, 12 parts of Semen Lepidii (Semen Descurainiae)s, 20 parts of the Rhizoma Pinelliaes, 20 parts of Rhizoma Corydalis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Semen Sinapis Albaes, 20 parts in Poria, 15 parts of Fructus Pruni persicae immaturuss, 15 parts of Fructus Lycii, 10 parts in Herba Ephedrae, 15 parts in Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 20 parts of the Radix Paeoniae Albas, 12 parts in Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment asthma may further comprise the steps:
(1) takes by weighing each crude drug according to described parts by weight;
Each crude drug that (2) will take by weighing is pulverized, is mixed;
(3) will get final product with the pack of every bag of 200-300 gram after the crude drug sterilization of mix homogeneously.
Embodiment 2:
A kind of Chinese medicine composition for the treatment of asthma is made by the crude drug of following weight portion: 25 parts of Fructus Schisandrae Chinensis, 10 parts of Herba Erodiis, 10 parts of Herba Gnaphalii Affinis, 8 parts of Pheretimas, 8 parts of Pumexs, 8 parts of Semen Lepidii (Semen Descurainiae)s, 15 parts of the Rhizoma Pinelliaes, 15 parts of Rhizoma Corydalis, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Semen Sinapis Albaes, 15 parts in Poria, 10 parts of Fructus Pruni persicae immaturuss, 10 parts of Fructus Lycii, 7 parts in Herba Ephedrae, 10 parts in Semen Armeniacae Amarum, 7 parts of Ramulus Cinnamomi, 15 parts of the Radix Paeoniae Albas, 8 parts in Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment asthma may further comprise the steps:
(1) takes by weighing each crude drug according to described parts by weight;
Each crude drug that (2) will take by weighing is pulverized, is mixed;
(3) will get final product with the pack of every bag of 200-300 gram after the crude drug sterilization of mix homogeneously.
Embodiment 3:
A kind of Chinese medicine composition for the treatment of asthma is made by the crude drug of following weight portion: 35 parts of Fructus Schisandrae Chinensis, 20 parts of Herba Erodiis, 20 parts of Herba Gnaphalii Affinis, 16 parts of Pheretimas, 16 parts of Pumexs, 16 parts of Semen Lepidii (Semen Descurainiae)s, 25 parts of the Rhizoma Pinelliaes, 25 parts of Rhizoma Corydalis, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Semen Sinapis Albaes, 25 parts in Poria, 20 parts of Fructus Pruni persicae immaturuss, 20 parts of Fructus Lycii, 13 parts in Herba Ephedrae, 20 parts in Semen Armeniacae Amarum, 13 parts of Ramulus Cinnamomi, 25 parts of the Radix Paeoniae Albas, 16 parts in Radix Glycyrrhizae.
The preparation method of the Chinese medicine composition of described treatment asthma may further comprise the steps:
(1) takes by weighing each crude drug according to described parts by weight;
Each crude drug that (2) will take by weighing is pulverized, is mixed;
(3) will get final product with the pack of every bag of 200-300 gram after the crude drug sterilization of mix homogeneously.
Experimental example:
One, clinical data: adopt the present invention to treat altogether 58 routine asthmatic patients, male 31 examples wherein, women 27 examples, the oldest 71 years old, minimum 6 years old of age.
Two, clinical symptoms: dyspnea with shortness of breath, dyspnea, even opening mouth and lifting shoulder due to dyspnea, flaring of nares, can not put down sleeping, lip cyanosis etc., two lung audible and wheezing sounds, or with moist rale.
Three, Therapeutic Method: the Chinese medicine decocting of making is boiled into decoction, and every pair of medicine can decoct three times, patient's every day early, middle and late respectively taking once, 7 days is a course for the treatment of.
Four, the standard of curative effect evaluation:
Cure: transference cure, experimental check is normal;
Take a turn for the better: symptom is obviously improved, and lab testing is improved;
Do not heal: primary symptom is not improved or deterioration person.
Five, model case:
1, Yang, the man, 33 years old, the teacher suffered from asthma 26 years, Symptoms is dyspnea, can not put down sleeping, two shoulder towering-ups, flaring of nares, two lung audible and wheezing sounds, or with moist rale; Take multi-medicament and substantially had no effect; Take Chinese medicine composition of the present invention after two courses for the treatment of symptom obviously improve, take four recoveries from illness courses for the treatment of; Followed up a case by regular visits to 2 years, and had no recurrence.
2, journey so-and-so, the man, 11 years old, the student suffered from asthma 8 years, Symptoms is dyspnea, can not strenuous exercise, hypoimmunity, easy catching a cold must be violated asthma after the flu, the state of an illness constantly increases the weight of in recent years, the then asthma of often coughing night; Took multi-medicament and be showed no effect, take Chinese medicine composition of the present invention after course for the treatment of symptom obviously improve, take three recoveries from illness courses for the treatment of; Followed up a case by regular visits to 2 years, and had no recurrence.
3, Zhao, the woman, 64 years old, retirement was suffered from asthma 11 years, whenever the outbreak of autumn in winter, Symptoms is the cough with asthma aggravation, gurgling with sputum, can not put down sleeping, anorexia, body of the tongue is light greenish blue; Took multi-medicament and be showed no effect, take Chinese medicine composition of the present invention after two courses for the treatment of symptom obviously improve; Take six recoveries from illness course for the treatment of; Followed up a case by regular visits to 1 year, and had no recurrence.
4, the side certain, the man, 52 years old, the peasant suffered from asthma 2 years, Symptoms be often asthma, can not work, fast, the long all asthma of walking, often flu, cough, abundant expectoration show effect repeatedly; Take multi-medicament and be showed no effect,
Take Chinese medicine composition of the present invention after course for the treatment of symptom obviously improve, take four recoveries from illness courses for the treatment of; Follow up a case by regular visits to so far, have no recurrence.
Six, therapeutic outcome:
Adopt the present invention to treat altogether 58 routine asthmatic patients, through the treatment of 3-4 the course for the treatment of, wherein cure 21 examples, 33 examples that take a turn for the better, 4 examples that do not heal, effective percentage is 93%; The result shows that the present invention is evident in efficacy to the asthma effect, and side effect is little.
Claims (2)
1. Chinese medicine composition for the treatment of asthma, it is characterized in that: the crude drug by following weight portion is made: Fructus Schisandrae Chinensis 25-35 part, Herba Erodii 10-20 part, Herba Gnaphalii Affinis 10-20 part, Pheretima 8-16 part, Pumex 8-16 part, Semen Lepidii (Semen Descurainiae) 8-16 part, Rhizoma Pinelliae 15-25 part, Rhizoma Corydalis 15-25 part, Radix Salviae Miltiorrhizae 15-25 part, Semen Sinapis Albae 15-25 part, Poria 15-25 part, Fructus Pruni persicae immaturus 10-20 part, Fructus Lycii 10-20 part, Herba Ephedrae 7-13 part, Semen Armeniacae Amarum 10-20 part, Ramulus Cinnamomi 7-13 part, Radix Paeoniae Alba 15-25 part, Radix Glycyrrhizae 8-16 part.
2. the Chinese medicine composition for the treatment of asthma according to claim 1, it is characterized in that: the crude drug by following weight portion is made: 30 parts of Fructus Schisandrae Chinensis, 15 parts of Herba Erodiis, 15 parts of Herba Gnaphalii Affinis, 12 parts of Pheretimas, 12 parts of Pumexs, 12 parts of Semen Lepidii (Semen Descurainiae)s, 20 parts of the Rhizoma Pinelliaes, 20 parts of Rhizoma Corydalis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Semen Sinapis Albaes, 20 parts in Poria, 15 parts of Fructus Pruni persicae immaturuss, 15 parts of Fructus Lycii, 10 parts in Herba Ephedrae, 15 parts in Semen Armeniacae Amarum, 10 parts of Ramulus Cinnamomi, 20 parts of the Radix Paeoniae Albas, 12 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310024742.3A CN103006955B (en) | 2013-01-23 | 2013-01-23 | Traditional Chinese medicine composition for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310024742.3A CN103006955B (en) | 2013-01-23 | 2013-01-23 | Traditional Chinese medicine composition for treating asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103006955A true CN103006955A (en) | 2013-04-03 |
| CN103006955B CN103006955B (en) | 2015-05-06 |
Family
ID=47956418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310024742.3A Expired - Fee Related CN103006955B (en) | 2013-01-23 | 2013-01-23 | Traditional Chinese medicine composition for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103006955B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105395746A (en) * | 2015-11-26 | 2016-03-16 | 龙启知 | Medicine for treating asthma in elderly |
| CN106237244A (en) * | 2016-08-30 | 2016-12-21 | 山东省文登整骨医院 | A kind of Chinese medicinal formulae treating asthma |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1994406A (en) * | 2006-12-26 | 2007-07-11 | 章丽美 | Orally administered Chinese medicine for treating qi-deficiency type asthma |
| CN102580020A (en) * | 2010-12-01 | 2012-07-18 | 介休市中医医院 | Traditional Chinese medicine composition for curing asthma |
-
2013
- 2013-01-23 CN CN201310024742.3A patent/CN103006955B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1994406A (en) * | 2006-12-26 | 2007-07-11 | 章丽美 | Orally administered Chinese medicine for treating qi-deficiency type asthma |
| CN102580020A (en) * | 2010-12-01 | 2012-07-18 | 介休市中医医院 | Traditional Chinese medicine composition for curing asthma |
Non-Patent Citations (1)
| Title |
|---|
| 陈华琼: "哮喘发作期152例用药特点的回顾分析", 《中国优秀硕士学位论文全文数据库》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105395746A (en) * | 2015-11-26 | 2016-03-16 | 龙启知 | Medicine for treating asthma in elderly |
| CN106237244A (en) * | 2016-08-30 | 2016-12-21 | 山东省文登整骨医院 | A kind of Chinese medicinal formulae treating asthma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103006955B (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341103B (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis and preparation method thereof | |
| CN101143176A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN101129892A (en) | Traditional Chinese medicine for treating aspiration pneumonia | |
| CN102205012A (en) | Medicament for treating allergic rhinitis and acute rhinitis | |
| CN103006955B (en) | Traditional Chinese medicine composition for treating asthma | |
| CN101647943B (en) | Medicinal composition | |
| CN101444593A (en) | Chinese traditional medical formula taken orally for curing asthma | |
| CN103463604A (en) | Drug for treating cough and asthma | |
| CN100364587C (en) | Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method | |
| CN103041251A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN102727738A (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof | |
| CN103341126B (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
| CN101647935B (en) | Medicinal composition | |
| CN104147334A (en) | Traditional Chinese medicine formula capable of eliminating phlegm | |
| CN104096148A (en) | Traditional Chinese medicine for treating infantile pneumonia | |
| CN102166340B (en) | Chinese medicine composition for treating sthenia heat edema | |
| CN103638323A (en) | Traditional Chinese medicine pill for treating chronic atrophic gastritis | |
| CN102755607B (en) | Medicine for treating bronchitis and asthma and preparation method thereof | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN103432540A (en) | Pellets for regulating and replenishing vital organs | |
| CN103316155B (en) | Traditional Chinese medicinal composition for treating constipation and preparation method thereof | |
| CN103223106B (en) | Traditional Chinese medicine used for treating yin-deficiency-type cough | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN102688381B (en) | Traditional Chinese medicine decoction of fructus ligustri lucidi for treating cough and preparation method | |
| CN103446570A (en) | Traditional Chinese medicine for treating chronic bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Baolan Inventor after: Xu Yuhong Inventor after: Lu Lianwei Inventor before: Ma Li |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160912 Address after: 14 Weifang, Shouguang City, Shandong Province, holy city street, building No. 110, No. 262700 Patentee after: Zhang Baolan Patentee after: Yang Wenwen Address before: 233300 Anhui city of Bengbu province Wuhe County District 10 Seasons Sunshine City 1 unit 301 room Patentee before: Ma Li |
|
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhan Inventor after: Yan Yan Inventor before: Zhang Baolan Inventor before: Xu Yuhong Inventor before: Lu Lianwei |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170330 Address after: 260000 Shandong city of Weifang province Anqiu city Huaian Jingzhi Town Road No. 106 Patentee after: Zhang Zhan Address before: 14 Weifang, Shouguang City, Shandong Province, holy city street, building No. 110, No. 262700 Patentee before: Zhang Baolan Patentee before: Yang Wenwen |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150506 Termination date: 20170123 |